CurrentRheuma
Get Weekly

CurrentRheuma coverage · page 21 of 48

Rheumatology (Oxford)

Briefs 801–840 of 1,905 CurrentRheuma has covered from this journal, newest publication first

Latest from Rheumatology (Oxford)

All coverage, newest first

  1. Rheumatology (Oxford)

    Effectiveness of pharmacological therapies for fibromyalgia syndrome in adults: an overview of Cochrane Reviews

    Research articleFibromyalgia & pain

  2. Rheumatology (Oxford)

    Psoriatic Arthritis Priority Setting Partnership: patient- and clinician-informed considerations for future UK health service delivery

    Cross-sectional studySpondyloarthritis & PsA

  3. Rheumatology (Oxford)

    Ultrasonography for the assessment of enthesitis in psoriatic arthritis: systematic review with meta-analysis

    Meta-analysisSpondyloarthritis & PsA

  4. Rheumatology (Oxford)

    Renal arteriosclerosis in kidney biopsies associated with higher 10-year atherosclerotic cardiovascular disease in lupus nephritis

    Cohort studyLupus & APS

  5. Rheumatology (Oxford)

    Improving the arthritis component of the SLEDAI-2K

    Secondary analysisLupus & APS

  6. Rheumatology (Oxford)

    Are ultrasound salivary parenchymal lesions more severe in primary Sjögren patients with a longer disease duration? A cross-sectional study

    Cross-sectional studySjögren's & overlap

  7. Rheumatology (Oxford)

    Biological hallmarks of systemic sclerosis are present in the skin and serum of patients with Very Early Diagnosis of Systemic Sclerosis (VEDOSS)

    Mechanistic studySystemic sclerosis

  8. Rheumatology (Oxford)

    A high polygenic risk score is associated with SSA/SSB antibody positivity and early onset in primary Sjögren’s disease

    Case-control studySjögren's & overlap

  9. Rheumatology (Oxford)

    Transforming growth factor-beta is increased in sputum from individuals with rheumatoid arthritis-associated pulmonary fibrosis

    Cross-sectional studyRA

  10. Rheumatology (Oxford)

    Systemic sclerosis–related fecal incontinence: a scoping review focusing on a neglected manifestation

    Research articleSystemic sclerosis

  11. Rheumatology (Oxford)

    Factors associated with early clinical remission in patients with idiopathic retroperitoneal fibrosis

    Cohort studyAutoinflammatory & rare

  12. Rheumatology (Oxford)

    The role of nailfold video-capillaroscopy in the assessment of dermatomyositis

    Cohort studyMyositis

  13. Rheumatology (Oxford)

    Insights into the 2023 ACR/EULAR antiphospholipid syndrome classification criteria: findings from a cohort of 205 patients with primary APS

    Cohort studyLupus & APS

  14. Rheumatology (Oxford)

    Comorbidity in incident rheumatoid arthritis: a nationwide case-control study with bidirectional follow-up

    Case-control studyRA

  15. Rheumatology (Oxford)

    Higher risk of poor functional outcome and unfavourable clinical events for late-onset rheumatoid arthritis: results from the IORRA cohort

    Cohort studyRA

  16. Rheumatology (Oxford)

    Incorporating computer vision on smart phone photographs into screening for inflammatory arthritis: results from an Indian patient cohort

    Diagnostic or prognostic studyRA

  17. Rheumatology (Oxford)

    Development and internal–external cross-validation of a patient-reported definition for acute calcium pyrophosphate crystal arthritis

    Cross-sectional studyGout & crystals

  18. Rheumatology (Oxford)

    Drug-induced liver injury related to avacopan therapy

    Cohort studyVasculitis & PMR

  19. Rheumatology (Oxford)

    Elevated Fcy receptor expression augments pro-inflammatory macrophage phagocytosis in systemic sclerosis and associated rheumatic diseases

    Mechanistic studySystemic sclerosis

  20. Rheumatology (Oxford)

    Increased risk of malignancy and osteoporosis in primary Sjögren’s syndrome with thyroid diseases: potential implication from T cells

    Cohort studySjögren's & overlap

  21. Rheumatology (Oxford)

    Integrating carotid Doppler, greyscale US, and aortic oscillometry to evaluate macroangiopathy in myositides: the MYOCARD cohort

    Cross-sectional studyMyositis

  22. Rheumatology (Oxford)

    Coronary artery calcium and atherosclerotic cardiovascular disease risk scores in patients with calcium pyrophosphate deposition disease

    Cross-sectional studyGout & crystals

  23. Rheumatology (Oxford)

    Compression ratio: a novel method to quantify compressibility as a diagnostic measurement in giant cell arteritis

    Diagnostic or prognostic studyVasculitis & PMR

  24. Rheumatology (Oxford)

    A deep dive into monogenic lupus: insights on DNASE1L3 mutation

    Cohort studyPediatric

  25. Rheumatology (Oxford)

    Cutaneous vasculitis in systemic lupus erythematosus: epidemiology and risk factors over a 20-year follow-up

    Cohort studyLupus & APS

  26. Rheumatology (Oxford)

    A protocol for targeted B-lymphocyte depletion for the treatment of IgG4-related disease

    Cohort studyAutoinflammatory & rare

  27. Rheumatology (Oxford)

    Nailfold videocapillaroscopy findings correlate with lung outcomes in idiopathic inflammatory myopathies–related interstitial lung disease

    Cohort studyMyositis

  28. Rheumatology (Oxford)

    Tocilizumab in cranial and extracranial giant cell arteritis: a national multicentre study of 471 cases

    Cohort studyVasculitis & PMR

  29. Rheumatology (Oxford)

    Blood pressure changes during methotrexate treatment: results from a randomized placebo-controlled trial among patients with cardiovascular risk

    Secondary analysisAcross diseases

  30. Rheumatology (Oxford)

    Longitudinal trajectories of the Scleroderma Health Assessment Questionnaire (SHAQ) visual analogue scales: a retrospective cohort study

    Cohort studySystemic sclerosis

  31. Rheumatology (Oxford)

    Risk factors of COVID-19 related hospitalization of paediatric patients with rheumatic diseases: a systematic review and meta-analysis

    Meta-analysisPediatric

  32. Rheumatology (Oxford)

    Association of validated patient reported outcome measures with patients’ self-reported disease status in axial spondyloarthritis

    Cohort studySpondyloarthritis & PsA

  33. Rheumatology (Oxford)

    Experiences with patient-initiated follow-up supported by asynchronous telemedicine in spondyloarthritis: a mixed methods study

    Cross-sectional studySpondyloarthritis & PsA

  34. Rheumatology (Oxford)

    A multivariable prediction model to identify anti-CCP positive people in those with non-specific musculoskeletal symptoms in primary care

    Diagnostic or prognostic studyRA

  35. Rheumatology (Oxford)

    Association of lupus low disease activity state and remission with reduced organ damage and flare in systemic lupus erythematosus patients with high disease activity: a multi-national, longitudinal cohort study

    Cohort studyLupus & APS

  36. Rheumatology (Oxford)

    Dermal cellular senescence and EndMT in patients with systemic sclerosis undergoing cyclophosphamide or aHSCT treatment

    Secondary analysisSystemic sclerosis

  37. Rheumatology (Oxford)

    Diagnosing a child presenting with symptoms suggesting Sjögren’s disease: a tool for clinical practice

    Diagnostic or prognostic studySjögren's & overlap

  38. Rheumatology (Oxford)

    Efficacy and safety of guselkumab in patients with active lupus nephritis: results from a phase 2, randomized, placebo-controlled study

    Randomized controlled trialLupus & APS

  39. Rheumatology (Oxford)

    Sustained drug-free remission in giant cell arteritis

    Cohort studyVasculitis & PMR

  40. Rheumatology (Oxford)

    Elevated serum interferon-α2 associates with activity and flare risk in juvenile-onset systemic lupus erythematosus

    Cross-sectional studyPediatric

All 1,905 Briefs in ExploreShowing Briefs 801–840 of 1,905, newest first